US device industry and FDA “colluded” on legislation to weaken regulatory oversight.

Lenzer J. BMJ. 2015-12-17 11:21:19, 2015;351.

US Food and Drug Administration officials had multiple meetings with leaders of the medical device industry to craft legislation that critics say will severely weaken regulatory oversight of the industry, an investigation by the online news service Inside Health Policy has found.

Read the full article here >

BMJJeanne Lenzer